Skip to main content
OpenTrials
Completed

NCT Number: NCT02248844

Safety and Effectiveness of BOTOX® for Lateral Canthal Lines With or Without Simultaneous Glabellar Lines in Korea

This is a postmarketing surveillance study in Korea to evaluate the safety and effectiveness of BOTOX® for lateral canthal lines (crow's feet lines) with or without simultaneous glabellar lines.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lateral Canthal Lines Crow's Feet Lines

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dr. Robbin Clinic

Gangnam-gu, Seoul, 135-839, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject and Investigator decision to treat crow's feet lines with Botox®

Exclusion criteria

  • None

Treatment and study plan

Botulinum toxin type A

Biological

Botulinum toxin Type A injected into crow's feet line areas per clinical practice.

Other names: BOTOX®, onabotulinumtoxinA

Primary outcomes

  1. Number of Participants with Adverse Events

    Time frame: Up to 3 months

Secondary outcomes

  1. Investigator's Assessment of Change in Appearance of Crow's Feet Lines on a 3-Point Scale

    Time frame: Baseline, Up to 3 months

  2. Subject's Assessment of Change in Appearance of Crow's Feet Lines on a 7-Point Scale

    Time frame: Baseline, Up to 3 months

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Sep 25, 2014
Registry last updated
Jul 5, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.